A mid-size publicly traded German dental firm gained FDA (PMA) approval for a unique oral surgery product but had no presence in the US. TCG built and managed a US subsidiary for the German parent: developed Key Opinion Leader (KOL) support and advertising for dental meetings, licensed related products and set up a sales force as well as FDA compliant warehousing and customer operations. US sales became substantial enough that another EU firm acquired the business at an attractive multiple, in part to get a US commercial presence.